Protagonist Therapeutics (PTGX) Q4 2023 Earnings

28FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.73
-0.34
0.05
0.44

Details

Expected EPS
0.053617
Actual EPS
0.44
Surprise EPS
0.39
Surprise Percent
+720.64%

Description

Protagonist Therapeutics (PTGX) has reported earnings of 0.44 per share for Q4 2023.

0 Comments

Share your thoughts